All News #Library
Sciences
CytoSen Receives FDA’s Response to Pre-IND Meeting for Ph 2 Study in AML
27 Sep 2018 //
BUSINESSWIRE
CytoSen Thera`s Receives FDA’s Favorable Response to Pre-IND Meeting for AML
27 Sep 2018 //
BUSINESSWIRE

Market Place
Sourcing Support